6 Patient Safety and Error Prevention

Medication safety and error prevention

Medication safety depends on reliable processes that prevent errors, detect them before they reach the patient, and support learning when they occur. A medication error is preventable and may lead to inappropriate medication use or patient harm. A near miss is intercepted before reaching the patient, while an adverse drug event is harm associated with medication use and does not necessarily mean an error occurred.

Reliable workflows and practical checks

Errors can arise during prescribing, order entry, dispensing, administration, or monitoring. Contributors include ambiguous directions, interruptions, workload, confusing packaging, incorrect data entry, and poorly organized storage. Prevention therefore depends on multiple safeguards, not only individual vigilance.

Pharmacy technicians support safe processes by following established procedures and confirming the patient and prescription identifiers required by the workflow. They select the exact drug, strength, dosage form, and quantity, then check the product and label against the order. Technology, including barcode systems, should be used as designed; alerts and required checks should not be bypassed without authorization.

Keep work areas organized, reduce avoidable interruptions, and pause to resolve discrepancies. If an order, calculation, product, or instruction seems unclear or inconsistent, stop and refer it to the pharmacist rather than guessing or changing the prescription independently.

A practical check, as applicable to the task, includes the right patient, medication, strength, dosage form, route, directions, and quantity. This checklist does not replace pharmacy policy, pharmacist verification, or patient-care checks performed by the person administering the medication.

Safeguards for high-alert medications

High-alert medications can cause serious harm when used in error. Errors may not happen more frequently with these drugs, but their consequences can be more severe. Examples on an acute-care list include insulin, anticoagulants, opioids, chemotherapy, neuromuscular blockers, concentrated electrolytes, and parenteral nutrition. Lists and safeguards differ by practice setting, so staff should follow the pharmacy’s current procedures.

Risk-reduction measures may include standardized concentrations and processes, restricted access, clear labeling, product separation, clinical decision support, and independent checks when policy requires them. A double-check does not replace a well-designed process and should be performed independently when specified. Technicians should recognize high-alert products, follow designated handling and verification steps, and promptly refer uncertainty to a pharmacist.

Preventing look-alike and sound-alike mix-ups

LASA drugs have names or packaging that look or sound similar but refer to different medications. FDA-recommended Tall Man lettering emphasizes the difference between the easily confused names DOBUTamine and DOPamine. Tall Man lettering can draw attention to name differences, but it does not eliminate the risk.

To reduce mix-ups:

• Read the complete drug name; do not rely on its first few letters, memory, or a familiar shelf location.

• Compare the name with the strength, dosage form, route, and indication when available and appropriate.

• Use pharmacy LASA alerts, Tall Man lettering, barcode checks, and required independent checks.

• Store confusing products separately when policy directs, and return stock to its correct location.

• Clarify an unclear handwritten, verbal, or electronic order through the pharmacist; never infer which drug was intended.

Potential name confusion is evaluated using factors such as spelling, pronunciation, and product characteristics.

Infection control during medication preparation

Standard Precautions apply in all care settings. Perform hand hygiene at appropriate times, including before an aseptic task and after glove removal; use soap and water when hands are visibly soiled. Wear personal protective equipment appropriate to the task and follow facility procedures for cleaning and disinfection.

Medication preparation should take place in a designated clean area separated from sinks and other contamination sources. Use aseptic technique when required, disinfect vial access diaphragms before entry, and use a new sterile needle and syringe for each entry. Never use a syringe or needle on more than one patient.

A single-dose vial or container is for one patient only. Do not pool, save, or reuse leftovers. Whenever possible, dedicate a multidose vial to one patient. If a multidose vial is used for multiple patients under applicable procedures, keep and access it in a designated clean medication area away from immediate treatment spaces. Discard medication if sterility is compromised or uncertain.

Sterile compounding requires specific training, competency, and compliance with applicable standards and facility procedures. Technicians should not prepare sterile products beyond their training or assigned role. Report contamination, a breached container, or a technique failure immediately.

Quality assurance and learning from events

Quality assurance uses routine checks and data to confirm that processes meet safety standards and to identify opportunities for improvement. A strong safety culture encourages prompt reporting of errors, near misses, and unsafe conditions according to workplace policy. Reporting supports learning and prevention: do not conceal an event or alter records. If an error may have reached a patient, notify the pharmacist or supervisor immediately so that appropriate clinical response and reporting can occur.

Organizations may review incident reports, dispensing audits, barcode overrides, inventory and storage checks, and infection-control observations. Root cause analysis reviews an event after it occurs to identify contributing system factors. Failure mode and effects analysis (FMEA) looks ahead to identify where a process could fail.

Improvement actions should address the underlying risk, such as unclear labeling, look-alike storage, workflow interruptions, or inadequate training. Monitor the actions afterward to see whether they work. Reporting near misses and errors helps identify system weaknesses and strengthen safeguards.

A system-wide responsibility

Medication safety is a shared, system-wide responsibility. Pharmacy technicians reduce risk by following standardized workflows, checking products carefully, recognizing high-alert and LASA medications, maintaining infection-control practices, and escalating uncertainty rather than guessing. Reporting errors and near misses helps the pharmacy identify system weaknesses and improve its safeguards.

• quality assurance (QA)